Standard Biotools (LAB) Share-based Compensation Growth (3y) (2013 - 2026)
Standard Biotools (LAB) Share-based Compensation Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.71 Bn | 194.11 Bn | 7.27 Bn | 8.37% |
| 2 | Stryker | 129.50 Bn | 126.03 Bn | 4.50 Bn | -28.31% |
| 3 | Medtronic | 119.85 Bn | 110.63 Bn | 6.41 Bn | 8.20% |
| 4 | Boston Scientific | 73.79 Bn | 73.25 Bn | 3.85 Bn | 13.19% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 4.11% |
| 6 | Dexcom | 34.58 Bn | 32.64 Bn | 830.00 Mn | -0.59% |
| 7 | GE HealthCare Technologies | 34.14 Bn | 32.03 Bn | 2.18 Bn | 17.13% |
| 8 | Koninklijke Philips | 26.45 Bn | 23.13 Bn | 4.55 Bn | 36.49% |
| 9 | Steris | 23.23 Bn | 22.74 Bn | 684.20 Mn | 3.40% |
| 10 | Standard Biotools | 258.06 Mn | -218.66 Mn | 10.54 Mn | 9.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.16% |
| Mar 31, 2026 | 16.68% |
| Dec 31, 2025 | 42.04% |
| Sep 30, 2025 | 18.81% |
| Jun 30, 2025 | 49.71% |
| Mar 31, 2025 | -77.51% |
| Sep 30, 2024 | 39.98% |
| Jun 30, 2024 | 30.00% |
| Mar 31, 2024 | -68.13% |
| Dec 31, 2023 | -38.84% |
| Sep 30, 2023 | 200.33% |
| Jun 30, 2023 | 199.42% |
| Mar 31, 2023 | 178.33% |
| Dec 31, 2022 | -46.27% |
| Sep 30, 2022 | 302.34% |
| Jun 30, 2022 | -131.81% |
| Mar 31, 2022 | 234.50% |
| Sep 30, 2021 | -34.02% |
| Jun 30, 2021 | 43.82% |
| Mar 31, 2021 | -33.02% |